• Klaus will lead the scale-up of AMSilk’s protein production with existing CMOs

• Klaus will be responsible for developing and implementing the future AMSilk strategy for protein production, including the development of capacities and new CMOs worldwide

• Klaus brings more than 25 years’ biotechnology experience in global operations

Klaus was most recently Head of Operations Enzymes at BASF and has previously worked for Uniobio, Novozymes and Orkla Foods leading their global operations and manufacturing. He has considerable experience in global operations and brings a deep understanding of product development, purchasing, engineering, process improvements, internal logistics and contract manufacturing. Klaus has worked across Europe, the US and Asia with multiple different strategies, processes and technologies.

Dr. Wolfgang Colberg Chairman of the Advisory Board, AMSilk, said: “The Board and I are very pleased to welcome Klaus to the AMSilk Management Team. AMSilk is entering a new phase of growth and the appointment of Klaus is a testament to AMSilk’s growth strategy, as we continue to drive the industrial upscaling of the Company.”

Ulrich Scherbel, Chief Executive Officer, AMSilk, said: “To have Klaus join the team is validation of our role as one of the world’s leading suppliers of innovative high-performance biotech materials. Klaus’ knowledge and experience of global manufacturing will be invaluable as we scale-up AMSilk’s protein production in 2022.”